Loading...
Loading...
By Karen Lellouche Tordjman - Tue, 03/21/2023 - 09:00
2023 may be another volatile year but companies should feel (cautiously) bullish about the opportunities ahead, writes Karen Lellouche Tordjman.
Featured content
Mon, 09/26/2022 - 08:49
Alfredo Nolasco, CEO and Founder, Spyral, discusses nearshoring and the end of globalization, the potential of Asian companies coming to the Mexican market and the opportunities for the public and private sectors to work together.
https://mexicobusiness.news/tag/health
More Professional Services
By Alejandro Luna - Wed, 12/07/2022 - 10:00
Alejandro Luna looks at the impact of Compulsory Licenses and provides potential alternatives.
By Fernando Lledó - Wed, 11/30/2022 - 11:00
All companies have the obligation to strengthen their ESG program, to share it and make their teams a true part of it, writes Fernando Lledó.
By Fernando Becerril - Mon, 10/31/2022 - 11:00
Intellectual capital is a trend that is gaining strength in Mexico, as evidence shows that it leads to success, writes Fernando Becerril.
By Armando Arenas - Mon, 09/05/2022 - 16:00
Prohibitions placed on labeling violate the principles of legality, legal order and legal certainty, writes Armando Arenas Reyes.
By Carlos Herrero - Thu, 02/03/2022 - 10:58
COVID pierced everything, from health to the economy and society. It is up to everyone to rebuild the foundations, writes Carlos Herrero.
By Fernando Becerril - Mon, 09/06/2021 - 13:03
IP a development engine that allows the world’s most important economies to advance, says Becerril Orta.
By Paloma Duran - Thu, 06/03/2021 - 15:48
Rodríguez explains the added value of incorporating disruptive technological solutions into legal processes.
By Fernando Becerril - Fri, 03/26/2021 - 12:39
New health-related laws and regulations are creating new challenges for the industry. BC&B’s Fernando Becerril explains.
By Fernando Becerril - Fri, 01/15/2021 - 13:06
From marijuana to medication procurement, there are many pending issues that need to be clarified from a regulatory point of view.
